GLPwatch
Trials (2139)
Page 17 of 36.
- Effect of Repeated Administration of Liraglutide on Insulinogenic Indices
- Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM)
- Cardiovascular Effects of GLP-1 Receptor Activation
- The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes
- Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patients
- Treatment of Diabetic Neuropathy With Liraglutide
- A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist
- Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying
- Clinical Trial for PB-119 in Subjects With Type 2 Diabetes Mellitus
- Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity
- Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real World
- Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake
- Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide
- Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes
- Study to Evaluate the Effect of Lixisenatide in Patient With Parkinson's Disease
- The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes
- A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)
- Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 Diabetes
- A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes
- Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
- Effect of Liraglutide on Heart Frequency in Healthy Volunteers
- Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1 Therapy Discontinuation
- A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects
- Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity
- Myocardial Protection of Exenatide in AMI
- Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
- A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients
- Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder
- Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity
- A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes
- Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy
- Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol
- Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjects
- Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures
- A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight
- The Semaglutide Study
- Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity
- Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.
- GLP-1 and Hyperoxia for Organ Protection in Heart Surgery
- iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)
- Semaglutide 2.4mg for Low Responders After Bariatric Surgery
- A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension
- Liraglutide in Adolescents With Type 1 Diabetes
- A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.
- Saxenda in Obesity Services (STRIVE Study)
- Tirzepatide Weight Loss for MRD+ Early Breast Cancer
- Autoinjector Device Assessment Study
- Semaglutide and Preoperative Residual Gastric Volumes
- A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.
- A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
- Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects
- A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese
- A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight
- A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms
- Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes
- Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male Subjects
- SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies
- A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus
- Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness
- Real-world Canadian Retrospective Study Evaluating Longitudinal Semaglutide Use on Cardio-Kidney-Metabolic Outcomes